Nanjing Vazyme Biotech Co., Ltd. (SHSE:688105) announces a share repurchase program. Under the program, the company will repurchase CNY 160 million worth of its shares. The shares will be purchased at a price not exceeding CNY 30 per share.

The repurchased shares will be used for the implementation of ESOP or equity incentive plan. The program will be valid for 12 months.